tumor fraction for patient selection in early phase trials: precision medicine analysis
Published 1 year ago • 50 plays • Length 0:31Download video MP4
Download video MP3
Similar videos
-
0:45
the significance of tumor fraction in the context of patient selection for oncology trials
-
53:16
edwin cuppen - whole-genome sequencing-based diagnostics for cancer precision medicine
-
8:18
part 2 - taking part in a early phase clinical trial - early phase clinical trials unit
-
30:48
designing proof-of-concept clinical trials - ashwin gollerkeri, m.d., pfizer
-
46:29
jacqueline buros: predicting survival from early tumor data in oncology clinical trials
-
39:38
precision medicine & clinical trials with anand karnad, m.d.
-
3:37
clinical trials at malnati brain tumor institute at northwestern explained
-
8:18
precision medicine in solid tumor malignancies
-
59:24
ers webinar : clinical trial design in the age of precision medicine
-
21:30
is personalised medicine a reality in today’s clinical cancer care practice?
-
7:20
part 1 - being recruited and accepted onto the early phase clinical trials unit
-
2:34
what is pancan’s know your tumor service?
-
34:35
phase i clinical trials 3.0
-
59:15
updates on: precision medicine - what is it and how does it apply to cancer treatment?
-
0:42
effects of precision medicine
-
55:45
phase ii clinical trials
-
4:44
phases of cancer clinical trials – an introduction, with neal meropol, md
-
1:06:01
multiscale analysis of in situ tumor biology towards precision medicine
-
26:01
clinical trials for brain tumors